January 23, 2020

Pharma Blisters Packaging Market Inclined to Deliver Positive Growth Results until 2026

Fact.MR has published a new research report on global pharma blister packaging market sizes, upcoming industry trends and growth opportunity through 2017-2026 to its online database that tries to unveil the various scenarios prevailing in the pharma blister packaging market. This assessment delivers a smart compilation of primary and secondary data which provides a clear insight about the future plans expected to impact the pharma blister packaging market. This study comprises of prominent data which makes it a beneficial source for investors, analysts and industry experts to acquire necessary knowledge associated to the fundamental market trends, opportunities and growth drivers.

There is a robust adoption of blisters packaging in the pharmaceutical industry, mainly driven by demand for tamper-evident & convenient packaging. Blisters packaging prevents compact medical devices and medicines from oxygen, odor, and moisture, along with enhancing their shelf life. The healthcare sector highly prefers blisters packaging on the back of its flexibility to unit-dose format coupled with extended visibility, implicit track & trace features, and expanded label content. Automation is increasingly eyed upon by vendors in the pharma blisters packaging market, in a bid to save time and reduce labor cost. Inclination toward smart blister packaging is one of the growing trends in the market. Many packaging industries are focusing on the development of smart blisters packs for combating medical counterfeiting and tracking status of drugs & medication during distribution and transportation processes.

According to a recently composed FactMR’s research report, the global market for pharma blisters packaging will exhibit a CAGR of 6.2% in terms of value during the forecast period (2017-2026). Sales of pharma blisters packaging are likely to surpass 1,900 thousand tons by 2026-end. Demand for pharma blisters packaging in North America will remain robust with increase in the patients’ poor medical compliance, which in turn leads to high hospital admissions. Many pharmaceutical packaging industries in the region are concentrating on the production of blister packages for enhancing adherence rate of patients. In addition, growing trend toward adhering to prescribed protocols in the United States healthcare system is likely to proliferate demand for pharma blisters packaging in North America. In terms of value, North America will prevail as the dominant region in the global pharma blisters packaging market.

Get A Sample Copy of Market Report Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=452

Tablets and medical devices are anticipated to remain largest applications of pharma blisters packaging, in terms of value. This mainly driven by the rise in OTC medicines and demand for devices such as single-use inhalers. Revenues from sales of pharma blisters packaging for medical devices and tablets will collectively account for roughly three-fourth market share by 2026-end.